Literature DB >> 12903594

[Undifferentiated carcinoma of the thyroid].

C Amodeo1, P Caglià, L Gandolfo, M Veroux, M Donati, A Immè.   

Abstract

Anaplastic thyroid carcinoma is a rare and highly lethal cancer. Between 1969 and 2002, 9 cases with anaplastic carcinoma were reviewed. Surgical treatment with radiotherapy and chemotherapy were performed in all cases. All patients died of their disease within 5 years. The mean survival was 10 months. There is still controversy as to what constitutes adequate treatment for anaplastic thyroid carcinoma, and combined multimodal therapy seems to be the most common management strategy for this aggressive disease.

Entities:  

Mesh:

Year:  2003        PMID: 12903594

Source DB:  PubMed          Journal:  Tumori        ISSN: 0300-8916            Impact factor:   2.098


  2 in total

1.  IGFBP7 inhibits cell proliferation by suppressing AKT activity and cell cycle progression in thyroid carcinoma.

Authors:  Le Zhang; Rong Lian; Jingjing Zhao; Xianming Feng; Runyi Ye; Lingxiao Pan; Jueheng Wu; Mengfeng Li; Yongbo Huan; Junchao Cai
Journal:  Cell Biosci       Date:  2019-06-06       Impact factor: 7.133

2.  Expression of Pax8 is decreased and bortezomib does not increase the iodine uptake in thyroid carcinoma cells.

Authors:  Huan-Jun Wang; Jin-Ming Yao; Zhong-Wen Zhang; Jun-Yu Zhao; Hong-Xia Shang; Lin Liao; Jian-Jun Dong
Journal:  Thorac Cancer       Date:  2015-07-14       Impact factor: 3.500

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.